
Globus Medical GMED
$ 86.48
-0.24%
Quarterly report 2025-Q3
added 11-06-2025
Globus Medical Cash and Cash Equivalents 2011-2025 | GMED
Annual Cash and Cash Equivalents Globus Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 784 M | 467 M | 150 M | 193 M | 239 M | 195 M | 140 M | 119 M | 133 M | 60.2 M | 82.3 M | 90 M | 212 M | 143 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 784 M | 60.2 M | 215 M |
Quarterly Cash and Cash Equivalents Globus Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 372 M | 229 M | 461 M | 623 M | 410 M | 354 M | 280 M | 306 M | 218 M | - | 134 M | 151 M | 230 M | 193 M | 362 M | 269 M | 185 M | 239 M | 251 M | 166 M | 167 M | 195 M | 166 M | 195 M | 130 M | 140 M | 140 M | 140 M | 140 M | 119 M | 119 M | 119 M | 119 M | 67 M | 133 M | 133 M | 133 M | 57.7 M | 60.2 M | 60.2 M | 60.2 M | 82.3 M | 82.3 M | 82.3 M | 82.3 M | 90 M | 90 M | 90 M | 90 M | 212 M | 212 M | 212 M | 212 M | 143 M | 143 M | 143 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 623 M | 57.7 M | 182 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
233 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.79 | -1.81 % | $ 131 M | ||
|
Bio-Rad Laboratories
BIO
|
488 M | $ 306.68 | -0.46 % | $ 8.65 B | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
183 M | $ 45.79 | 1.46 % | $ 6.82 K | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
7.62 B | $ 128.4 | 2.33 % | $ 223 B | ||
|
Boston Scientific Corporation
BSX
|
414 M | $ 92.01 | -0.6 % | $ 135 B | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.16 | 9.55 % | $ 118 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 9.59 | -2.74 % | $ 689 M | ||
|
InMode Ltd.
INMD
|
68.9 M | $ 14.36 | -1.03 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
7.03 M | $ 0.98 | 5.89 % | $ 15.8 M | ||
|
IRadimed Corporation
IRMD
|
52.2 M | $ 96.66 | 0.44 % | $ 1.22 B | ||
|
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
1.04 B | $ 163.43 | -1.21 % | $ 12.2 B | ||
|
Accuray Incorporated
ARAY
|
57.4 M | $ 1.05 | -0.94 % | $ 108 M | ||
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
20.1 M | $ 12.55 | -1.3 % | $ 339 M | ||
|
FONAR Corporation
FONR
|
46.8 M | $ 14.83 | 0.54 % | $ 97.2 M | ||
|
AxoGen
AXGN
|
27.6 M | $ 29.82 | -1.88 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
24.5 M | $ 40.28 | -1.33 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
429 M | $ 62.88 | 0.21 % | $ 3.41 B | ||
|
OrthoPediatrics Corp.
KIDS
|
43.8 M | $ 17.67 | 0.4 % | $ 408 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 13.54 | 0.86 % | $ 1.04 B | ||
|
LENSAR
LNSR
|
16.3 M | $ 11.6 | 0.78 % | $ 134 M | ||
|
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
139 M | $ 19.95 | -0.08 % | $ 2.85 B | ||
|
Aethlon Medical
AEMD
|
5.5 M | $ 3.15 | -7.35 % | $ 4.92 M | ||
|
Establishment Labs Holdings
ESTA
|
90.3 M | $ 72.06 | -0.63 % | $ 2.03 B |